[Congressional Record Volume 161, Number 51 (Thursday, March 26, 2015)]
[Senate]
[Page S2061]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 984. Mr. HATCH (for himself and Mr. Bennet) submitted an amendment 
intended to be proposed by him to the concurrent resolution S. Con. 
Res. 11, setting forth the congressional budget for the United States 
Government for fiscal year 2016 and setting forth the appropriate 
budgetary levels for fiscal years 2017 through 2025; as follows:

       At the appropriate place, insert the following:

     SEC. ___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO THE 
                   ESTABLISHMENT OF A LIMITED POPULATION APPROVAL 
                   FOR ANTIBACTERIAL DRUGS.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to the treatment of serious or life-threatening 
     infections for which there is an unmet medical need, and 
     which may include the establishment by the Food and Drug 
     Administration of a limited population approval pathway to 
     bring to market new antibacterial drugs, by the amounts 
     provided in such legislation for those purposes, provided 
     that such legislation would not increase the deficit over 
     either the period of the total of fiscal years 2016 through 
     2020 or the period of the total of fiscal years 2016 through 
     2025.
                                 ______